Publication | Closed Access

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial

Potential ImpactHuman RetrovirusImmunologyAntiviral TherapyAntiviral ResponseProviral Hiv-1 DnaAntiviral DrugHivMedicineIntensified Antiretroviral Therapy